Bringing innovative medicines to the world's markets.
Irifar is a privately held pharmaceutical company based in Ireland. We in-license innovative, branded originator medicinal products and register, market and promote them across international markets, delivered to patients through a trusted network of distributor partners.
- Headquarters
- Dublin
- Markets served
- Four regions
- Therapeutic areas
- Five
- Portfolio
- Originator
For originators & licensors
Bring your medicine to new markets
Originator and innovator companies looking to extend a branded medicine into Asia, the Middle East, Africa and Eastern Europe without building local infrastructure.
Find out more →For distributors & trade partners
Add innovative medicines to your portfolio
National and regional distributors, importers and trade partners seeking innovative, branded originator products that are registered and ready for their market.
Find out more →01
Who we are
Innovative medicines change lives, but only where patients can reach them.
Irifar exists to close that gap. We partner with originators and innovators to in-license their branded products and take responsibility for registering, marketing and promoting them in international markets, delivered through established local distributors.
This focused model has a single purpose: to bring innovative therapies to the markets that need them, across Asia, the Middle East, Africa and Eastern Europe.
Read the full company profile →
02
What we do
Irifar focuses on innovative, branded originator products, not generics, concentrating on specialty and hospital therapeutic areas where access to innovative medicines matters most.
In-Licensing
Innovative originator products
We in-license branded, innovative medicines from originator and innovator companies.
Registration & Market Access
Authorised in every market
We obtain the authorisations and registrations that make each product available in its market.
Marketing, Promotion & Distribution
Delivered through partners
We market and promote each brand and deliver it through a global distributor network.
03
Therapeutic areas
Five focused areas, many of them specialty and hospital-based, where access to innovative, branded originator medicines has the greatest impact on patient outcomes.
View our therapeutic areas →04
A growing in-licensed portfolio
A growing portfolio of in-licensed assets across our therapeutic areas, and expanding through new originator partnerships.
View the full portfolio →
05
A route to market, built on trust
We work with the originators and innovators whose medicines we in-license, and with the distributors who carry them the last mile into their markets.
-
Exclusive in-licensing
Exclusive in-licensing agreements for innovative originator products entering new markets.
-
Territory-based distribution
Territory-based distribution agreements giving distributors access to our portfolio.
-
Marketing & promotion
Marketing and promotion partnerships building demand for innovative brands.
-
Long-term supply
Long-term supply partnerships structured around reliability and growth.
Innovation only matters where patients can reach it.
Let's talk.
Have an innovative product seeking new markets, or a market seeking innovative products?
Partner with us